← Leaderboards
Robert H Mealey
Washington State University
$2,557,888
Attributed
$2,557,888
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $734K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,557,888 · 6
By mechanism
R21$1,660,521 · 4
K02$710,100 · 1
K08$187,267 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington State University
Same institution · by research overlap
- Susan Carpenter$1,488,154
- Travis C. McGuire$2,021,289
- Kristin M Hasel$247,103
- Darrilyn G Fraser$72,612
- Jerald L Oaks$414,746
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteNeutralizing AntibodyViralBiological ModelsCessation Of LifeProtective EffectInfectionResponseVaccinesVaccine DesignB-LymphocytesVirusEpitopesDefectEquus CaballusImmuneCytotoxic T LymphocyteEquine Infectious Anemia VirusCd8-Positive T-LymphocytesResearch StudyAntibody-Mediated ProtectionCapsid ProteinsAcuteCommunicable Diseases
Grant awards (14)
Hepacivirus control by T cells and broadly active antibodies$228,000
R21 · FY2017 · AI · contact PI
Hepacivirus control by T cells and broadly active antibodies$189,896
R21 · FY2016 · AI · contact PI
Lentivirus Control by CTL and Neutralizing Antibody$142,020
K02 · FY2011 · AI · contact PI
Lentivirus Control by CTL and Neutralizing Antibody$142,020
K02 · FY2010 · AI · contact PI
Lentivirus Control by CTL and Neutralizing Antibody$142,020
K02 · FY2009 · AI · contact PI
Lentivirus Control by CTL and Neutralizing Antibody$142,020
K02 · FY2008 · AI · contact PI
Lentivirus Control by CTL and Neutralizing Antibody$142,020
K02 · FY2007 · AI · contact PI
EIAV Control by DNA Vaccine-Induced CTL$215,025
R21 · FY2006 · AI · contact PI
EIAV Control by High Avidity Rev-Specific CTL Clones$293,600
R21 · FY2005 · AI
EIAV vector targeting dendritic cells to induce CTL$220,200
R21 · FY2005 · AI
EIAV Control by DNA Vaccine-Induced CTL$220,200
R21 · FY2005 · AI
EIAV Control by High Avidity Rev-Specific CTL Clones$293,600
R21 · FY2004 · AI
ADOPTIVE TRANSFER OF CD8+ CTLS TO CONTROL EIAV$110,754
K08 · FY2001 · AI
ADOPTIVE TRANSFER OF CD8+ CTLS TO CONTROL EIAV$76,513
K08 · FY2000 · AI